JONATHAN HERO CHUNG

Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology SAN DIEGO, CA NPI 1508878752

General Payments — all program years on this page

$678,916.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 296
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $165,849.37 across 50 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Daiichi Sankyo Inc. $123,165.0029
Boehringer Ingelheim Pharmaceuticals, Inc. $32,197.0814
AstraZeneca UK Limited $4,387.292
ABBVIE INC. $3,850.004
BeiGene USA, Inc. $2,250.001

By program year

Program yearAmountRecords
2018 $119,252.7869
2019 $72,282.1450
2020 $32,849.4710
2021 $26,625.7516
2022 $94,470.3938
2023 $167,586.8563
2024 $165,849.3750

Records — PY2024 (50)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089409346 Daiichi Sankyo Inc. $3,867.50 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409348 Daiichi Sankyo Inc. $3,570.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409350 Daiichi Sankyo Inc. $3,570.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409352 Daiichi Sankyo Inc. $3,421.25 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409354 Daiichi Sankyo Inc. $3,272.50 01/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409356 Daiichi Sankyo Inc. $2,677.50 02/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409358 Daiichi Sankyo Inc. $2,975.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409360 Daiichi Sankyo Inc. $3,570.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409362 Daiichi Sankyo Inc. $3,421.25 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409364 Daiichi Sankyo Inc. $2,677.50 05/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409366 Daiichi Sankyo Inc. $4,313.75 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409368 Daiichi Sankyo Inc. $5,652.50 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409370 Daiichi Sankyo Inc. $2,677.50 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409372 Daiichi Sankyo Inc. $2,826.25 07/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409374 Daiichi Sankyo Inc. $3,570.00 06/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409376 Daiichi Sankyo Inc. $4,611.25 06/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409378 Daiichi Sankyo Inc. $3,570.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409380 Daiichi Sankyo Inc. $7,288.75 07/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409382 Daiichi Sankyo Inc. $2,975.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409384 Daiichi Sankyo Inc. $4,462.50 03/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409386 Daiichi Sankyo Inc. $2,528.75 03/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409388 Daiichi Sankyo Inc. $3,421.25 04/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409390 Daiichi Sankyo Inc. $3,272.50 01/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409392 Daiichi Sankyo Inc. $18,296.25 10/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409394 Daiichi Sankyo Inc. $1,041.25 07/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409396 Daiichi Sankyo Inc. $3,421.25 04/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409398 Daiichi Sankyo Inc. $3,718.75 05/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409400 Daiichi Sankyo Inc. $6,693.75 07/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089409402 Daiichi Sankyo Inc. $5,801.25 02/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093977626 AstraZeneca UK Limited $896.79 02/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093997927 AstraZeneca UK Limited $3,490.50 08/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103132925 ABBVIE INC. $1,650.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103132927 ABBVIE INC. $1,100.00 05/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103132929 ABBVIE INC. $550.00 06/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1103132931 ABBVIE INC. $550.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118039096 Boehringer Ingelheim Pharmaceuticals, Inc. $116.42 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039098 Boehringer Ingelheim Pharmaceuticals, Inc. $123.86 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039100 Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 10/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118039102 Boehringer Ingelheim Pharmaceuticals, Inc. $767.10 09/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118039104 Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.00 05/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118039106 Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.00 05/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118039108 Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039110 Boehringer Ingelheim Pharmaceuticals, Inc. $48.98 08/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118039112 Boehringer Ingelheim Pharmaceuticals, Inc. $100.29 06/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118039114 Boehringer Ingelheim Pharmaceuticals, Inc. $115.43 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118039116 Boehringer Ingelheim Pharmaceuticals, Inc. $3,375.00 08/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118039118 Boehringer Ingelheim Pharmaceuticals, Inc. $3,750.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118039120 Boehringer Ingelheim Pharmaceuticals, Inc. $4,875.00 11/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118039122 Boehringer Ingelheim Pharmaceuticals, Inc. $12,000.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1120866968 BeiGene USA, Inc. $2,250.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.